170 related articles for article (PubMed ID: 30038340)
1. Identification, structure modification, and characterization of potential small-molecule SGK3 inhibitors with novel scaffolds.
Gong GQ; Wang K; Dai XC; Zhou Y; Basnet R; Chen Y; Yang DH; Lee WJ; Buchanan CM; Flanagan JU; Shepherd PR; Chen Y; Wang MW
Acta Pharmacol Sin; 2018 Dec; 39(12):1902-1912. PubMed ID: 30038340
[TBL] [Abstract][Full Text] [Related]
2. Identification and Kinetic Characterization of Serum- and Glucocorticoid-Regulated Kinase Inhibitors Using a Fluorescence Polarization-Based Assay.
Kim J; Kim D; Jung H; Lee J; Hong VS
SLAS Discov; 2021 Jun; 26(5):655-662. PubMed ID: 33783250
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the structure and regulation of two novel isoforms of serum- and glucocorticoid-induced protein kinase.
Kobayashi T; Deak M; Morrice N; Cohen P
Biochem J; 1999 Nov; 344 Pt 1(Pt 1):189-97. PubMed ID: 10548550
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel serum and glucocorticoid regulated kinase-1 (SGK1) ligand from virtual screening.
Geldenhuys WJ; Talasila PK; Sadana P
Bioorg Med Chem Lett; 2012 Sep; 22(17):5675-8. PubMed ID: 22858098
[TBL] [Abstract][Full Text] [Related]
5. Probing 2H-Indazoles as Templates for SGK1, Tie2, and SRC Kinase Inhibitors.
Schoene J; Gazzi T; Lindemann P; Christmann M; Volkamer A; Nazaré M
ChemMedChem; 2019 Aug; 14(16):1514-1527. PubMed ID: 31264364
[TBL] [Abstract][Full Text] [Related]
6. Design and Characterization of SGK3-PROTAC1, an Isoform Specific SGK3 Kinase PROTAC Degrader.
Tovell H; Testa A; Zhou H; Shpiro N; Crafter C; Ciulli A; Alessi DR
ACS Chem Biol; 2019 Sep; 14(9):2024-2034. PubMed ID: 31461270
[TBL] [Abstract][Full Text] [Related]
7. De novo design of protein kinase inhibitors by in silico identification of hinge region-binding fragments.
Urich R; Wishart G; Kiczun M; Richters A; Tidten-Luksch N; Rauh D; Sherborne B; Wyatt PG; Brenk R
ACS Chem Biol; 2013 May; 8(5):1044-52. PubMed ID: 23534475
[TBL] [Abstract][Full Text] [Related]
8. Role of the Phox homology domain and phosphorylation in activation of serum and glucocorticoid-regulated kinase-3.
Tessier M; Woodgett JR
J Biol Chem; 2006 Aug; 281(33):23978-89. PubMed ID: 16790420
[TBL] [Abstract][Full Text] [Related]
9. Virtual Screening Approach to Identify High-Affinity Inhibitors of Serum and Glucocorticoid-Regulated Kinase 1 among Bioactive Natural Products: Combined Molecular Docking and Simulation Studies.
Mohammad T; Siddiqui S; Shamsi A; Alajmi MF; Hussain A; Islam A; Ahmad F; Hassan MI
Molecules; 2020 Feb; 25(4):. PubMed ID: 32070031
[TBL] [Abstract][Full Text] [Related]
10. Phosphoproteomics reveals that the hVPS34 regulated SGK3 kinase specifically phosphorylates endosomal proteins including Syntaxin-7, Syntaxin-12, RFIP4 and WDR44.
Malik N; Nirujogi RS; Peltier J; Macartney T; Wightman M; Prescott AR; Gourlay R; Trost M; Alessi DR; Karapetsas A
Biochem J; 2019 Oct; 476(20):3081-3107. PubMed ID: 31665227
[TBL] [Abstract][Full Text] [Related]
11. Identification of Novel Pyruvate Dehydrogenase Kinase 1 (PDK1) Inhibitors by Kinase Activity-Based High-Throughput Screening for Anticancer Therapeutics.
Zhang W; Hu X; Chakravarty H; Yang Z; Tam KY
ACS Comb Sci; 2018 Nov; 20(11):660-671. PubMed ID: 30350563
[TBL] [Abstract][Full Text] [Related]
12. Discovery of novel pyruvate dehydrogenase kinases inhibitors by screening of an in-house small molecule library for anti-lung cancer therapeutics.
Guo F; Zhao S; Li X
Bioorg Med Chem Lett; 2019 Jan; 29(2):291-296. PubMed ID: 30470491
[TBL] [Abstract][Full Text] [Related]
13. NH2 terminus of serum and glucocorticoid-regulated kinase 1 binds to phosphoinositides and is essential for isoform-specific physiological functions.
Pao AC; McCormick JA; Li H; Siu J; Govaerts C; Bhalla V; Soundararajan R; Pearce D
Am J Physiol Renal Physiol; 2007 Jun; 292(6):F1741-50. PubMed ID: 17356130
[TBL] [Abstract][Full Text] [Related]
14. High-throughput Docking and Molecular Dynamics Simulations towards the Identification of Novel Peptidomimetic Inhibitors against CDC7.
Makhouri FR; Ghasemi JB
Mol Inform; 2018 Nov; 37(11):e1800022. PubMed ID: 29984527
[TBL] [Abstract][Full Text] [Related]
15. Identification and further development of potent TBK1 inhibitors.
Richters A; Basu D; Engel J; Ercanoglu MS; Balke-Want H; Tesch R; Thomas RK; Rauh D
ACS Chem Biol; 2015 Jan; 10(1):289-98. PubMed ID: 25540906
[TBL] [Abstract][Full Text] [Related]
16. The serine/threonine kinases SGK2 and SGK3 are potent stimulators of the epithelial Na+ channel alpha,beta,gamma-ENaC.
Friedrich B; Feng Y; Cohen P; Risler T; Vandewalle A; Bröer S; Wang J; Pearce D; Lang F
Pflugers Arch; 2003 Mar; 445(6):693-6. PubMed ID: 12632189
[TBL] [Abstract][Full Text] [Related]
17. Regulation of KCNE1-dependent K(+) current by the serum and glucocorticoid-inducible kinase (SGK) isoforms.
Embark HM; Böhmer C; Vallon V; Luft F; Lang F
Pflugers Arch; 2003 Feb; 445(5):601-6. PubMed ID: 12634932
[TBL] [Abstract][Full Text] [Related]
18. Small-molecular, non-peptide, non-ATP-competitive polo-like kinase 1 (Plk1) inhibitors with a terphenyl skeleton.
Mita Y; Noguchi-Yachide T; Ishikawa M; Hashimoto Y
Bioorg Med Chem; 2013 Feb; 21(3):608-17. PubMed ID: 23276450
[TBL] [Abstract][Full Text] [Related]
19. Computational insights into the active structure of SGK1 and its implication for ligand design.
Akhoon BA; Gandhi NS; Pandey R
Biochimie; 2019 Oct; 165():57-66. PubMed ID: 31302161
[TBL] [Abstract][Full Text] [Related]
20. K+ channel activation by all three isoforms of serum- and glucocorticoid-dependent protein kinase SGK.
Gamper N; Fillon S; Feng Y; Friedrich B; Lang PA; Henke G; Huber SM; Kobayashi T; Cohen P; Lang F
Pflugers Arch; 2002 Oct; 445(1):60-6. PubMed ID: 12397388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
